MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.470
-0.110 (-6.96%)
At close: Dec 5, 2025, 4:00 PM EST
1.480
+0.010 (0.68%)
After-hours: Dec 5, 2025, 7:37 PM EST
MaxCyte Market Cap
MaxCyte has a market cap or net worth of $156.81 million as of December 5, 2025. Its market cap has decreased by -53.98% in one year.
Market Cap
156.81M
Enterprise Value
69.24M
1-Year Change
-53.98%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since the IPO on March 10, 2021, MaxCyte's market cap has decreased from $494.67M to $156.81M, a decrease of -68.30%. That is a compound annual growth rate of -21.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 168.54M | -61.67% |
| Dec 31, 2024 | 439.69M | -9.93% |
| Dec 29, 2023 | 488.14M | -12.55% |
| Dec 30, 2022 | 558.17M | -45.87% |
| Dec 31, 2021 | 1.03B | 108.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |